Check in often for a current list of national research funding and award opportunities with upcoming deadlines.
Ongoing
- Due: LOI submission rolling
- Funding: Up to $75,000 per year
- Project period: 1 to 2 years
- Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
- Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.
- Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
- Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
- Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
- Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
- Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.
- Due: Rolling
- Funding: $100,000
- Project period: 1 to 3 years
- Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
- Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.
- Due: Rolling
- Funding: $100,000 to $1M
- Project period: 1 to 2 years
- Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
- Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.
- Due: Open
- Funding:Up to $1M
- Project period: Up to 3 years
- Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
- Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.
- Due: Rolling; submission deadlines for subsequent review ocurring on August 15
- Funding: Up to $100,000 per year
- Project period: 1 to 2 years
- Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
- Eligibility: Researchers at all levels are eligible.
- Due: Open
- Funding: Not Specified
- Project period: Not Specified
- Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
- Eligibility: Intended for U.S. based researchers.
Brutten Family Foundation – Grants
- Due: Open
- Funding: Not Specified
- Project period: Not Specified
- Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
- Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.
Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant
- Due: Rolling submission
- Funding: Up to $10,000
- Project period: Not specified
- Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
- Eligibility: Researcher should have necessary data in hand at time of application submission.
- Due: LOI submission rolling
- Funding: Negotiable
- Project period: Not specified
- Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
- Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.
- Due: January 1 (Round 1); July 1 (Round 2) annually
- Funding: $25,000-$50,000
- Project period: 1 to 2 years
- Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
- Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.
- Due: During and up to 4 months after active award period
- Funding: $14,000 per year maximum
- Project period: One-time payment
- Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
- Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.
- Due: Rolling
- Funding: Stipend (amount not specified)
- Project period: 1 year
- Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
- Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.
Diamond Blackfan Anemia Foundation – Research Grant
- Due: Rolling
- Funding: Not specified
- Project period: Not specified
- Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
- Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.
- Due: Rolling (LOI)
- Funding: Not specified
- Project period: Not specified
- Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
- Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.
- Due: February 15 and August 15 annually
- Funding: $250,000
- Project period: 2 years
- Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
- Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.
Foundation for Anesthesia Education and Research (FAER) – Research Training Grants
- Due: February 15 and August 15 annually
- Funding: $75,000
- Project period: 1 year
- Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
- Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.
- Due: Rolling
- Funding: $75,000
- Project period: 1 year
- Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
- Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.
- Due: Rolling LOI submission
- Funding: Not specified
- Project period: Not specified
- Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
- Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.
- Due: Rolling
- Funding: $200,000 to $1.5 M
- Project period: 2 to 5 years
- Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
- Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
- Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.
- Due: Rolling
- Funding: $200,000 to $1.5 M
- Project period: 2 to 5 years
- Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
- Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
- Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.
- Due: Rolling
- Funding: $200,000 to $800,000
- Project period: 2 to 5 years
- Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
- Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
- Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.
- Due: Rolling
- Funding: $100,000 minimum
- Project period: Not specified
- Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
- Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.
- Due: Open; Concept Proposals accepted year-round
- Full applications accepted by invitation
- Funding: Not specified
- Project period: Not specified
- Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
- Note: ITN does not accept proposals for non-human or preclinical studies.
- Due: Open
- Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
- Project period: Not specified
- Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
- Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.
- Due: Rolling
- Funding: $30,000 per year
- Project period: 1 to 2 years
- Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
- Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.
- Due: Rolling pre-application
- Full applications accepted by invitation
- Funding: Not specified
- Project period: Not specified
- Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
- Eligibility: Open to industry and industry-academia collaborations.
- Due: Standard March dates.
- Funding: Up to $150,000 per year
- Project period: Up to 5 years
- Purpose: To provide protected time for conducting postdoctoral mentored global health research in low- and middle-income countries to strengthen global health research.
- Due: Varies by awarding IC
- Funding: Up to $50,000 direct costs
- Project period: Up to 1 year
- Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
- Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.
- Due: Varies by awarding IC
- Funding: Up to $50,000 direct costs
- Project period: Up to 1 year
- Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.
- Due: Rolling through May 7, 2029
- Funding: Not specified
- Project period: Up to 5 years
- Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
- Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.
- New Applications due: annually on June 12, October 12
- Renewal/Revision/Resubmission: annually on March 12, July 12, November 12
- All Types Due: annually on April 8, August 8, December 8
- Standard Receipt Dates: June 16, October 16
Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants
- Due: Rolling
- Funding: Up to $4,000
- Project Period: 6 months.
- Purpose: To fund statistical and/or publication support of active PeDRA Studies
- Eligibility: Study Support Grants are available to PeDRA Members only. Please login or join PeDRA to access deadline details and other content.
- Due: Rolling
- Funding: Not specified
- Project Period: 1 to 3 years
- Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
- Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.
- Due: Rolling
- Funding: Not specified
- Project period: 2 years
- Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
- Eligibility: Applicants must be fellows or early-stage faculty.
- Due: Rolling
- Funding: $50,000
- Project period: Up to 2 years
- Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
- Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.
- Due: Rolling
- Funding: Not specified.
- Project period: 2 years
- Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
- Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.
- Due: Open
- Funding: Not specified
- Project period: Up to 3 years
- Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
- Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.
The Milbank Foundation – Grants
- Due: Open (LOIs required)
- Funding: Not specified
- Project period: Not specified
- Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
- Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.
- Due: Rolling (LOI)
- Funding: Not specified
- Project period: Not specified
- Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
- Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.
W.K. Kellogg Foundation – Grants
- Due: Open (LOIs accepted at any time)
- Funding: Not specified
- Project period: Not specified
- Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
- Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.
July
- Due : July 15, 2025 (Pre-Proposal)
- Funding: Breakthrough Grants: Up to $2M; Catalyst Grants: Up to $500k
- Project Period: Up to 2 years
- Purpose: Breakthrough Grants support interdisciplinary teams investigating novel neuroinflammation mechanisms and the potential development of new biomarkers, therapeutic targets, or technologies. At least three institutions must be part of the team. Catalyst Grants are designed to help researchers overcome critical research hurdles and support high-risk, high reward research projects that explore and innovated, interdisciplinary approaches to neuroinflammation that have potential to lead to significant advances in diagnosis, treatment, or prevention.
- Eligibility: The PI should hold an MD, PhD, or equivalent terminal clinical degree. Basic, translational, or clinical investigators from public and private non-profit organization and biotechnology/pharmaceutical companies or other publicly or privately held for-profit organizations are eligible to apply.
- Due: July 15, 2025
- Funding: Up to $30,000
- Project Period: 1 year
- Purpose: To support studies by advanced doctoral students and postdoctoral researchers affiliated with a university or museum. Current funding focus areas include: Paleoanthropology of the Miocene, Pliocene, and Pleistocene, Primates, and modern hunter-gatherer groups. Up to $20,000 for predoctoral students.
- Eligibility: Advanced predoctoral degree students and postdoctoral researchers affiliated with a university are eligible.
- Due: July 15, 2025
- Funding: $100,000 (paid over 1 year)
- Project Period: Up to 2 years
- Purpose: To support the nation’s top postdoctoral fellow by enabling them to complete mentored training under a leading senior scientist and to encourage the pursuit of bold ideas.
- Eligibility: Damon Runyon Fellows in the last year of their fellowship, current fellows selected in November 2021, May 2022, and February 2023. Fellows who have terminated their awards early to accept an independent academic faculty position or other funding are eligible to apply.
- Due: July 15, 2025
- Funding: Up to $30,000
- Project Period: 1 year
- Purpose: To support studies by advanced doctoral students and postdoctoral researchers affiliated with a university or museum. Current funding focus areas include: Paleoanthropology of the Miocene, Pliocene, and Pleistocene, Primates, and modern hunter-gatherer groups. Up to $20,000 for predoctoral students.
- Eligibility: Advanced predoctoral degree students and postdoctoral researchers affiliated with a university are eligible.
- Due: July 15, 2025 (concept submission)
- Funding: Up to $550,000
- Project Period: Up to 3 years
- Purpose: To provide opportunities for new scientists to gain the research experience in child health necessary to establish themselves as independent research scientists.
- Eligibility: Physicians in a residency/fellowship training program, or who completed that program no more than one year before the Concept Paper deadline and postdoctoral researchers who received their terminal doctoral degree no more than three years prior to Concept Paper deadline.
- Due: July 23, 2025
- Funding: Up to $100,000/year in Phase 1; Up to $325,000/year in Phase 2
- Project Period: Up to 2 years mentored support in Phase 1; up to 5 years for independent research in Phase 2
- Purpose: To provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management, and cures, and to attract and retain brilliant scientists in the diabetes research field.
- Eligibility: Initiator Award: Postdoctoral fellows and research fellows with no more than 7 years or research training post terminal degree are eligible. NIH K99/R00 awardees are not eligible. Institutional nominations and support required.
Accelerator Award: Early career faculty proposing innovative and ambitious diabetes-related research who have demonstrated independent productivity in diabetes research may apply. Applicants holding an NIH K, U, or R (including an initial R01/U01) award may apply, but candidates must not have applied for or received an R01/U01 renewal or a second R01/U01 award. Institutional nominations and support required.
- Due: July 23, 2025
- Funding: Up to $297,024
- Project Period: Up to 3 years
- Purpose: To support innovative pilot projects focused on predicting and understanding protein-protein and protein-small molecule interactions involved in key biological processes associated with cardiovascular, kidney, and metabolic diseases, including obesity. Use of the AHA’s Protein Portal is encouraged for these projects.
- Eligibility: Applicants must hold an MD, PhD, DMD, DO, PharmD, DVM or equivalent from an accredited institution, (recent doctoral degree should have been received no more than five years prior to application submission). Applicant fellowship positions must be at university affiliated institutions or other non-profit research institutions within the United States and U.S. possessions (U.S. citizenship or permanent residency, or appropriate work visas and permits required). Applications should have less than 4 years of research experience to apply. Institutional nominations and support required.
- Due: July 23, 2025
- Funding: Up to $30,000
- Project Period: Up to 18 months
- Purpose: To support Quality Improvement (QI) projects that integrate Share Decision Making (SDM) tools and care algorithms into hemophilia patient care.
- Eligibility: Medical, dental, nursing, allied health, and/or pharmacy professional schools, healthcare institutions (both large and small), professional organizations; government agencies, and other entities with a mission related to improving healthcare may apply.
- Due: July 23, 2025
- Funding: Up to $250,000
- Project Period: 3 years
- Purpose: Supports independent medical education activities that will increase knowledge of new guideline-based treatment recommendations involving the recently updated NCCN Bladder Guidelines for all stages of disease, including locally advanced or metastatic bladder cancer.
- Eligibility: Institutions may apply (medical, nursing, allied health, and/or pharmacy professional schools, healthcare institutions, professional organizations/medical societies, medical education companies, and other entities with a mission related to healthcare professional education and/or healthcare improvement).
- Due: July 23, 2025
- Funding: Up to $250,000
- Project Period: Up to 2 years
- Purpose: A collaboration between Pfizer, Conquer Cancer, the ASCO Foundation, The American Society for Radiation Oncology(ASTRO), and Large Urology Group Practice Association (LUGPA) to support independent research initiatives that will focus on improving the patient experience and management of care throughout the bladder cancer continuum, from diagnosis to survivorship, utilizing a multidisciplinary approach to care.
- Eligibility: Intended for medical, surgical, and radiation oncologists, urologists, nurses, advanced practice providers and other members of the multi-disciplinary team treating patients with bladder cancer in various settings (including academic and community settings). Primary applicant must be U.S. based; collaborative sites outside of the U.S. are allowed.
- Due: July 24, 2025
- Funding: Up to $200,000
- Project Period: 3 years
- Purpose: To support studies focused on generating evidence on the use of elranatamab in multiple myeloma in the real-world setting. Primary areas of interest include examining safety and efficacy, outpatient administration of the medication, impact of prior treatments on outcomes. See other areas of interest. A total of $250,000 may be available if there is strong scientific justification and well-supported budget details.
- Eligibility: This grant will be awarded to institutions that are legally able to receive award funding directly from Pfizer Inc. PIs must be an employee or contractor of the requesting organization and have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with an MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
- Due: July 24, 2025
- Funding: $50,000
- Project Period: 1 year
- Purpose: To foster development of the next generation of cancer researchers and innovation and advance translation of promising ideas in metastatic breast cancer research, including the exploration of potential therapeutic targets and biomarkers by supporting projects that seek to bridge basic science with emerging treatment strategies.
- Eligibility: Applicants should have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field, be an independent investigator working at an academic, medical, or non-profit research institution, and must meet citizenship requirements if applying from an institution that is not located in their country of citizenship, permanent residency or will hold an appropriate visa for the duration of the project.
- Due: July 24, 2025
- Funding: Up to £250,000
- Project Period: Up to 8 years (part-time available)
- Purpose: To support mid-career scientists in any discipline who have the potential to be international research leaders.
- Eligibility: Mid-career researchers who are ready to lead a substantial and innovative research program to generate significant shifts in understanding and/or develop methodologies, conceptual frameworks, tools or techniques that could benefit health-related research.
- Due: July 28, 2025
- Funding: Up to$100,000
- Project Period: Up to 2 years
- Purpose: To support projects related to promoting lifelong learning and certifying psychiatrists and neurologists to high standards of expertise.
- Eligibility: Applicants must hold a faculty appointment in a Psychiatry or Neurology department at an LCME-accredited medical school. Non-faculty applicants must submit a chair-approved offer letter confirming a start date before January 1, 2026. MD and DO applicants must be certified by ABPN, participate in ABPN’s continuing certification program and hold an unrestricted license to practice medicine in a state, commonwealth, territory, or possession of the U.S.
- Due: July 28, 2025
- Funding: Up to$120,000
- Project Period: Up to 2 years
- Purpose: To support the development of innovative education and/or evaluation projects that promote effective residency/fellowship training or lifelong learning of practicing psychiatrists and neurologists. Priority will be given to projects that first-time applicants, applicants who are at the junior or mid-faculty level and to projects that have applicability to more than one site.
- Eligibility: Applicants must hold a faculty appointment in a Psychiatry or Neurology department or equivalent at a U.S. based LCME-accredited medical school, be certified by ABPN with active participation in continuing certification, and comply with ABPN’s conflict of interest policies and procedures. Priority will be given to projects that first-time applicants, applicants who are at the junior or mid-faculty level and to projects that have applicability to more than one site.
- Due: July 29, 2025
- Funding: $130,000
- Project Period: 2 years
- Purpose: To help postdoctoral and clinical research fellows establish successful careers in the immuno-oncology research field by supporting basic, translational, clinical, or population sciences related projects that have direct applicability to immuno-oncology.
- Eligibility: Applicants must hold a mentored research position as a postdoctoral fellow, clinical research fellow or equivalent at an academic, medical ore research institution and have completed their most recent doctoral degree or medical residency within the past five years (cannot be conferred before November 1, 2020).
- Due: July 31, 2025 (LOI)
- Funding: $60,000
- Project Period: Not specified
- Purpose: To support innovative interventions based on evidence-based psychological principles that advance the field of psychology and address urgent needs of communities.
- Eligibility: Individuals or organizations that have demonstrated competence and capacity to carry out the proposed project are eligible to apply. An expert in evidence-based psychology practices/knowledge must be centrally involved throughout the duration of the project.
- Due: July 31, 2025
- Funding: $80,000
- Project Period: Up to 2 years
- Purpose: To support research directly related to acute care physical therapy practice and relevant to acute care in addressing one for more priority areas of the 2023 APTA Research Agenda.
- Eligibility:The PI must hold a PhD, DSc, or EdD or equivalent, or hold a master’s or certificate that required at least eight credit hours in research design and methodologies; if a DPT, show at least one year of research methods coursework; or have an expert on the research team who is explicitly responsible for providing the requisite design and methodological skills and experience. The PI must work at a domestic, public or private, non-profit or for-profit organization or institution that is eligible to receive research grants and will act as the sponsoring institution. A physical therapist/physical therapist assistant license to practice in the U.S. is required. Applicants must be a member of APTA and APTA Acute Care. U.S. citizenship or permanent residency with a valid Green Card, or a non-immigrant foreign citizenship with a valid visa is required. See other eligibility requirements for applying.
- Due: July 31, 2025
- Funding: $40,000
- Project Period: Up to 2 years
- Purpose: To support diagnostic, prognostic, rehabilitative or therapeutic intervention or practice in physical therapy that will decrease cardiovascular disease risks and improve cardiovascular and pulmonary outcomes. Proposals must be relevant to priority areas of the 2023 APTA Research Agenda
- Eligibility: The PI must hold a PhD, DSc, or EdD or equivalent, or hold a master’s or certificate requiring eight or more credit hours in research design and methodologies; if a DPT, have one year of research methods coursework; or have an expert on the research team who is explicitly responsible for providing the requisite design and methodological skills and experience. The PI must work at a domestic, public or private, non-profit or for-profit organization or institution that is eligible to receive research grants. A physical therapist/physical therapist assistant license to practice in the U.S. is required. Applicants must be a member of APTA and the APTA Academy of Cardiovascular & Pulmonary Physical Therapy. U.S. citizenship or permanent residency with a valid Green Card, a non-immigrant foreign citizen with a valid visa is required. See other eligibility requirements for applying.
- Due: July 31, 2025
- Funding: $40,000
- Project Period: Up to 2 years
- Purpose: To support research that evaluates the effectiveness of physical therapist interventions in any discipline relevant to physical therapy, and addresses one or more priority area(s) of the APTA 2023 Research Agenda.
- Eligibility: The PI must hold a PhD, DSc, or EdD or equivalent, or hold a master’s or certificate requiring eight or more credit hours in research design and methodologies; if a DPT, have one year of research methods coursework; or have an expert on the research team who is explicitly responsible for providing the requisite design and methodological skills and experience. The PI must work at a domestic, public or private, non-profit or for-profit organization or institution that is eligible to receive research grants. A physical therapist/physical therapist assistant license to practice in the U.S. is required. Applicants must be a member of APTA. U.S. citizenship or permanent residency with a valid Green Card, a non-immigrant foreign citizen with a valid visa is required. See other eligibility requirements for applying.
- Due: July 31, 2025
- Funding: $40,000
- Project Period: Up to 2 years
- Purpose: To support research that examines clinical outcomes of physical therapy practice for patients with musculoskeletal conditions. The proposed study should address one or more priority area(s) of the 2023 APTA Research Agenda.
Eligibility: Open to emerging investigators (researchers with some previous research experience who have not yet been awarded and NIH R01 or equivalent, or established researchers changing directions in their research focus within an existing field or beginning in a new field). The PI must hold a PhD, DSc, or EdD, or equivalent, work at a domestic, public or private, non-profit or for-profit organization or institution that is eligible to receive research grants and have a physical therapist/physical therapist assistant license to practice in the U.S. Applicants must be a member of APTA and of the Academy of Orthopaedic Physical Therapy. U.S. citizenship or permanent residency with a valid Green Card, or non-immigrant foreign citizen with a valid visa is required. See other eligibility requirements for applying.
- Due: July 31, 2025
- Funding: $40,000
- Project Period: Up to 2 years
- Purpose: To support basic science experimental research, clinical research related to individuals with developmental disabilities across various settings (home, school, clinic, hospital, or community, health services research, development and validation of evaluative measurement tools, implementation science, or analysis of large secondary datasets) to answer relevant questions. Applicants will need to demonstrate that their proposed research is a priority area(s) in the APTA Pediatrics Research Agenda 2024-2026.
Eligibility: Open to emerging investigators (researchers with some previous research experience who have not yet been awarded and NIH R01 or equivalent, or established researchers changing directions in their research focus within an existing field or beginning in a new field). The PI must hold a PhD, DSc, or EdD, or equivalent, work at a domestic, public or private, non-profit or for-profit organization or institution that is eligible to receive research grants, and have a physical therapist/physical therapist assistant license to practice in the U.S. Applicants must be a member of APTA and of the Academy of Orthopaedic Physical Therapy. U.S. citizenship or permanent residency with a valid Green Card, or non-immigrant foreign citizen with a valid visa is required. See other eligibility requirements for applying.
- Due: July 31, 2025
- Funding: $40,000
- Project Period: Up to 2 years
- Purpose: To support research that evaluates the effectiveness of physical therapist interventions in any discipline relevant to physical therapy, and addresses one or more priority area(s) of the APTA 2023 Research Agenda.
Eligibility: The PI must hold a PhD, DSc, or EdD or equivalent, or hold a master’s or certificate requiring eight or more credit hours in research design and methodologies; if a DPT, have one year of research methods coursework; or have an expert on the research team who is explicitly responsible for providing the requisite design and methodological skills and experience. The PI must work at a domestic, public or private, non-profit or for-profit organization or institution that is eligible to receive research grants. A physical therapist/physical therapist assistant license to practice in the U.S. is required. Applicants must be a member of APTA. U.S. citizenship or permanent residency with a valid Green Card, a non-immigrant foreign citizen with a valid visa is required. See other eligibility requirements for applying.
August
- Due: August 1, 2025 (LOI)
- Funding: $10,000 per year
- Project Period: 1 year (up to 2 years with justification)
- Purpose: To support clinical and basic science research involving health care outcomes in the practice of osteopathic medicine, with an emphasis on the use of osteopathic manipulative treatment (OMT) in patient care. Research topics may include but are not limited to benchtop physiological models research, educational standards development, practice guidelines research, normative data collection and clinical research.
- Eligibility: No research level specified. Submission of full application is by invitation only after LOIs are reviewed.
- Due: August 1, 2025 (LOI)
- Funding: $600,000
- Project Period: Up to 4 years
- Purpose: To provide research support for promising early-career to foster invention of methods, instruments and materials that will open up new avenues of scientific research. Full funding (over 4 years) is based on research progress.
- Eligibility: Applicants must be within the first four years of a tenure-track position (or equivalent) at a U.S.-based academic or non-profit institution that conducts research in chemical and life sciences. U.S. citizenship or permanent residence required (conditional permanent residents and individuals who have applied for permanent residency but have not received their government documentation are eligible). Check other eligibility requirements.
Society for Academic Emergency Medicine Foundation (SAEMF) – SAEMF Grants
- Due: August 1, 2025
- Funding: Varies per mechanism
- Project Period: Varies per mechanism
- Purpose: To support emergency medicine academicians (who are SAEMF members) at varying levels by providing research experience and career development opportunities to help them advance in their careers and become established researchers in the field of emergency medicine research.
- Eligibility: Varies per mechanism. MD, DO, PhD, DSc or equivalent with an academic appointment required.
Research Training Grant (RTG) – $300,000, 2-year mentored grant to support the development of sound research skills and encourage the awardee’s academic development and involvement in emergency medicine research. K awardees and VA CDA recipient are not eligible.
Research Large Project Grant (LPG) – $150,000, 2-year grant for an emergency medicine faculty with an academic appointment in a department or division of emergency medicine or pediatric emergency medicine, to conduct a large-scale research project that has potential for obtaining subsequent federal funding. R01 awardees are not eligible. Membership required.
Education Research Training Grant (ERG) – $100,000, 2-year grant to support an early career researcher with leadership potential (no more than 8 years post terminal degree) in education research training. The awards seek to foster innovation in teaching, education, and educational research in emergency medicine for faculty-, fellow-, resident- and medical student-level learners.
SAEMF Emerging Infectious Disease and Preparedness Grant – $100,000, 1-year grant to support emergency care research related to emerging infectious disease and proposals involving an ambitious program of research that can lead to sustained, externally supported funded research. Faculty members applying as mentored or independent research scientists may apply. Independent researchers must have a track record of high-quality publications or prior funding that demonstrates a career stage appropriate for the applicant’s career stage.
SAEMF/ED Benchmarking Alliance Clinical Operations Research Grant – $50,000, 2-year grant to support an emergency medicine faculty member or trainee conducting research on emergency department clinical operations to investigate patients’ experiences during an ED stay. An academic appointment in a department or division of emergency medicine or pediatric medicine is required. Faculty members applying as mentored or independent research scientists may apply. Independent researchers must have a track record of high-quality publications or prior funding that demonstrates a career stage appropriate for the applicant’s career stage.
SAEMF ARMED Pilot Grant – $25,000 from SAEMF with $25,000 of matching funds from the awardee’s department ($50,000 total) for a 1-year mentored research project for an emergency medicine academician, to encourage the pursuit of an academic career in emergency medicine research. Academic appointment in a department or division of emergency medicine or pediatric medicine is required. Applicants must have graduated from the SAEM Advanced Research Methodology Evaluation and Design Course. K-series and VA CDA awardees are not eligible.
- Due: August 6, 2025
- Funding: $100,000 to $1,000,000 (major research grants)
- Project Period: 2 to 4 years
- Purpose: To support research on strategies to improve the use of research evidence in ways that benefit young people ages 5-25 in the US. Studies involving secondary data analysis are typically between $100,000 to $300,000; studies involving new data collection are typically between $300,000 to $600,000. Officers’ Research Grants $25,000 to $50,000 over 1 to 2 years.
- Eligibility: Tax-exempt organizations are eligible.
- Due: August 12, 2025
- Funding: $750,000
- Project Period: Up to 3 years
- Purpose: To advance Assistant Professors and recently appointed Associate Professors (MDs and PhDs) who are emerging as scientific leaders.
- Eligibility: Applicants must be employed full-time at an academic or non-profit institution, be independent investigators at the Asst. Professor or Assoc. Professor rank (promoted to Assoc Professor before Oct 1, 2022) with evidence of long-term institutional support, be tenure-track faculty or equivalent, and must have completed formal post-doctoral research training post-PhD within the past 7 years or no more than 12 years from date of completed residency for MD or MD/PhD applicants. Applicants must also have an established track record of research accomplishments (publications in high-impact journals, awards, and other metrics or peer recognition) in cognitive aging. Evidence of institutional commitment must be submitted via a form completed by the Dean or CEO, along with a letter of commitment signed by the Department Chair.
- Due: August 15, 2025
- Funding: Up to $50,000
- Project Period: 1 year
- Purpose: To support studies that investigate various aspects of hearing and balance disorders associated with the inner ear. Special Interests: Causes of Sudden Hearing Loss and Menier’s Disease.
- Eligibility: Priority is given to early career investigators who need seed funding to generate preliminary data that can be used to apply for larger grants administered by the NIH or other entities.
- Due : August 15, 2025
- Funding: Stipend of $70,000 (slight increase each year)
- Project Period: Up to 4 years
- Purpose: To support individuals with innovative project ideas in basic or clinical research that have the potential to significantly impact the prevention, diagnosis, or treatment of one or more pediatric cancers.
- Eligibility: Candidates must hold an MD, PhD, MD/PhD, DDS, DVM, DO. Level 1 applicants: Basic and physician-scientist must have received their degrees no more than 18 months prior to the application deadline and have no more than 1 year working in their sponsor’s lab by application deadline. 100% protected time required. Level 2: physician-scientists with MD, MD/PhD, DDS, DVM, DO or equivalent must have completed residency and clinical training and be board eligible in the U.S. by award start date. 80% protected time required.
Foundation for Anesthesia Education and Research (FAER) – Research Fellowship Grants
- Due: August 15, 2025
- Funding: $75,000
- Project Period: 1 year
- Purpose: To provide anesthesiology residents and fellows with the opportunity to acquire significant training in research techniques and scientific methods.
- Eligibility: For graduate physicians enrolled in an ACGME-accredited residency program in anesthesiology or who have been accepted into a clinical fellowship program sponsored by an ACGME-accredited residency program in anesthesiology, and be no more than 10 years post completion of any foreign anesthesiology residency training. The particular clinical fellowship program doe3s no need to be ACGME-accredited. Prior to beginning their FAER research project, a recipient must have completed at least six months of research as part of their core residency program (CA1 – CA3). ASA membership required.
- Due: August 15, 2025
- Funding: $250,000
- Project Period: 2 years
- Purpose: To support anesthesiology early career faculty members who are pursuing careers as independent physician-scientists to help them develop the skills and preliminary data needed for research publishing and obtaining larger grants.
- Eligibility: For faculty members who are licensed to practice medicine or osteopathy in at least one state or jurisdiction of the U.S., have completed their core anesthesiology training within the past 10 years, are focused on any area of research that will contribute to advancement in patient care and potentially lead to extramural research (including basic science, clinical, translational, health services and education research. U.S. citizenship or permanent residency, or H-1 visa status (valid through the duration of the project) are required. 75% protected time required.
- Due: August 15, 2025
- Funding: $100,000
- Project Period: 2 years
- Purpose: To support the advancement anesthesiologists who are interested in improving the concepts, methods and techniques of education in anesthesiology by proposing innovative approaches for anesthesia education.
- Eligibility: For graduate physicians (from an accredited ACGME anesthesiology residency program) with an active medical or osteopathy license. Applicants must be certified by the American Board of Anesthesiology or in the examination system. The FAER Grants Management Committee will consider applicants with acceptance into the ABA Alternative Entry Path (AEP). U.S. citizenship or permanent residency, or H-1 visa status (valid through the duration of the project) are required. 40% protected time and ASA membership required.
- Due: August 15, 2025
- Funding: $75,000
- Project Period: 1 year
- Purpose: To provide seed funding to support basic and clinical scientist and investigators focused on testing innovative ideas for improving diagnosis treatment/therapy, patient care, early diagnosis, detection, cancer biology, basic science, prevention/metabolism and research core facilities.
- Eligibility: US academic institutions and research organizations are eligible to apply. The funding opportunity is available to all academic researchers, including research-track and clinical-track faculty, staff scientists, and postdoctoral trainees.
- Due: August 15, 2025 (Online Funding Inquiry (OFI))
- Funding: Not specified
- Project Period: Not specified
- Purpose: To support novel and fundamental on a broad range of areas and topics, including origins of life, complexity, emergence, evolution, human development, and ecological health and interventions. Areas of interest: Science of Purpose; Epigenetic inheritance; other innovative ideas in basic research in the biological sciences, including evolution, human development, plant resilience, and ecological health and interventions.
- Eligibility: None specified. By invitation only after review of a submitted OFI.
- Due: August 15, 2025 (LOI)
- Funding: Up to $50,000
- Project Period: 1 year
- Purpose: To support outstanding preclinical, translational, or clinical research proposals directly related to multiple system atrophy, cerebellar subtype (MSA-C) that aim to make significant advancements in treatment and care of individuals affected by the disease.
- Eligibility: Applicants must be independent researchers. Priority will be given to proposals that accelerate development of disease-modifying therapies, support clinical trail readiness, develop new or improved existing methods for accurate and timely diagnosis, bridge the gap between scientific discovery and therapeutic application, and significantly advance or reshape mechanistic understanding of MSA-C pathogenesis.
- Due: August 15, 2025 (LOI)
- Funding: Up to $100,000
- Project Period: 1 year
- Purpose: To support outstanding translational or clinical research predominantly focused on making significant advancements in the development of treatment and/or improvements to patient care for Spinocerebellar Ataxia Type 3 (SCA3). The primary focus of proposals should be on preclinical, translational, or clinical research directly related to SCA3.
- Eligibility: Full-time faculty members (clinical fellows, or senior scientist) at an academic institution, non-profit organization, or for-profit company, who have completed training postdoctoral training may apply.
- Due: August 15, 2025 (LOI)
- Funding: Up to $50,000
- Project Period: 1 year
- Purpose: To support new and innovative studies in the early or pilot phase and serve as additional support for ongoing investigations on demonstration of need for research relevant to understanding the cause, pathogenesis or treatment of the hereditary, sporadic, and acquired ataxias. It is expected that funded projects will generate preliminary data needed to obtain larger grants from other funding sources.
- Eligibility: Applicants must hold a full-time appointment as a faculty member, clinician, or senior scientist
(with completed postdoctoral training more than five years before the start of the funding term) at an academic institution, non-profit organization, or for-profit company.
- Due: August 21, 2025
- Funding: Up to $350,000
- Project Period: 2 years
- Purpose: To support projects focused on increasing healthcare professional knowledge and competence in 1) Guideline concordance and best practices for integration of testing into clinical practice, 2) Emerging data on efficacy and safety regarding PARPi’s used in the treatment of MPC, 3) Clinical data regarding PARPi combinations and how to mitigate associated side effects for optimal patient care, and 4) Best practices for initiating guideline concordant care for patients with mPC in community healthcare setting for optimal therapy management of PARPi combination in prostate cancer.
- Eligibility: Community oncologists, urologists, oncology nurses and nurse practitioners, physician assistants, pharmacists, genetic counselors, and other healthcare professionals involved in the care and treatment of patients with mCRPC working at a U.S.-based institution may apply. Organizations will receive the grant and must be accredited if projects offer continuing education credit.
- Due: August 31, 2025 (concept submission)
- Funding: Up to $300,000
- Project Period: Up to 2 years
- Purpose: To support research designed and conducted by independent clinicians and scientists through our Investigator Sponsored Studies (ISS) program. Areas of interest: Schizophrenia & Bipolar 1 Disorder, Schizophrenia, and Substance Use Disorders. Types of research considered: interventional, observational, monitoring/surveillance, use of registry data, historical chart review, secondary research or met-analysis and patient-reported outcomes.
- Eligibility: Applicants must have an MD, PhD, PS, PharmD, NP, RN, or equivalent.
- Due: August 31, 2025
- Funding: Varies
- Project Period: Varies
- Purpose: To support innovative research in challenging areas of future importance.
- Eligibility: Scientists at any level affiliated with any research-based institution, university or company are eligible.
Smart Consumables for Digital Integration in Biomanufacturing Processes – Up to 120,000 EUR per year for up to three years with potential further collaboration.
Multi-purpose Micro-Physiological Systems – to improve translatability and reduce the use of animals in the testing of drug and chemical compounds. Grant will be negotiated on a case by case basis.
September
- Due: September 1, 2025 (LOI)
- Funding: Up to $80,000 per year
- Project Period: 5 years
- Purpose: To honor full professors who have made seminal contributions to the field of cancer research and will continue to make impactful contributions to change the direction of research. Commitment and success in scientific mentoring and leadership, and community engagement will be considered.
- Eligibility: For full professors.
- Due: September 1, 2025
- Funding:stipend $74,000 year 1; $76k year 2; $78k year 3
- Project Period: Up to 3 years
- Purpose: To support hypothesis-driven, mechanistic studies by qualified early career scientists at leading universities and research centers worldwide, who seek training in fundamental immunology or cancer immunology.
- Eligibility: Applicants must have a doctorate degree with 5 or more years of relevant postdoctoral experience (M.D. applicants should not include years of residency in this calculation) and be working in areas directly related to immunology or cancer immunology at a non-profit institution. Completion of eligibility questionnaire required.
Note: CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
CRI Immuno-Informatics Postdoctoral Fellowship
- Due: September 4, 2025
- Funding: Annual stipend $62,232 – $75,564 based on years of experience + $12,200 annually (for health insurance), and $3,000 per year for project support
- Project Period: Up to 2 years; 2-year renewal available based on research progress
- Purpose: To enhance the training of postdoctoral researchers who are not yet independent.
- Eligibility: Applicants must hold an MD, PhD, DMD, DO, PharmD, DVM, PhD in nursing or equivalent from an accredited institution, (with no more than five years of research training after obtaining a doctorate degree prior to application submission). Applicant fellowship positions must be at university affiliated institutions or other non-profit research institutions within the United States and U.S. possessions (U.S. citizenship or permanent residency, or appropriate work visas and permits required). 80% protected time required. This award is not for individuals of faculty rank. Awards are limited to U.S.-based non-profit institutions. An awardee must maintain an AHA-accepted visa through the duration of the grant.
- Due: September 5, 2025 (LOI)
- Funding: $224,000
- Project Period: 2 years
- Purpose: The Arnold O. Beckman Postdoctoral Fellowship in Chemical Sciences or Chemical Instrumentation Award Program supports for advanced research by postdoctoral scholars working within the core areas of fundamental chemistry or the development and build of chemical instrumentation. An optional third year is available based on progress, with $118,000 of funding for salary, fringe and research expenditures.
- Eligibility: Visa holders are not eligible to apply. Current graduate students with an anticipated PhD completion date by May 1, 2026, or current postdoctoral researchers in the chemical sciences with no more than 18 months of research experience are eligible. Candidates must have a sponsoring mentor (or co-mentor) who holds a PhD or MD/PhD, is a full-time tenured or tenure-track (or equivalent) faculty with at least a 25% appointment in a department affiliated with chemistry, chemical physics, chemical engineering, or the chemistry of materials science at a U.S-based institution. Candidates must pursue postdoctoral research training in one of the aforementioned areas. U.S. citizens or permanent residents of the United States or its possessions or hold Deferred Action for Childhood Arrivals (DACA) recipient status eligible. Check other eligibility requirements.
- Due: September 9, 2025
- Funding: $450,000
- Project Period: 3 years
- Purpose: To support early career investigators pursuing an academic career in clinical, basic, or translational neurologic research.
- Eligibility: AAN members who are neurologists and completed residency between 5-10 years prior to award start date (July 1, 2026). MD/PhDs and fellows post residency are eligible based on residency completion date.
- Due: September 9, 2025
- Funding: $150,000
- Project Period: Up to 2 years
- Purpose: To recognize the importance of good clinical research and to encourage early career investigators who are interested in an academic career in neurological research to conduct clinical studies in clinical research in neurology and more specific areas such as ALS, Frontotemporal Degeneration (FTD), and other neurological disorders. AAN funding will be provided in collaboration with various partners.Areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research. Disease-related research not involving human subjects will be considered it the goal is to develop therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
- Eligibility: PI must have an MD, PhD, or equivalent doctoral-level clinical degree (with completed clinical residency or PHD no more than 5 years prior to July 1, 2026). For MD/PhDs eligibility is based on residency completion date even if a fellowship was completed afterwards. Research should be patient-oriented conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These awards also seek to encourage early career scientists to pursue and establish careers patient-oriented research in the various areas of neurological research.
Clinical Research Training Scholarship – to cover education and research-related costs.
Clinical Research Training Scholarship in ALS – Partnership funding provided with The ALS Association & the American Brain Foundation for clinical research studies in ALS.
Clinical Research Training Scholarship in FTD – Partnership funding provided with the Holloway Family Fund of The Association for Frontotemporal Degeneration and the American Brain Foundation for clinical studies in FTD by clinical care providers interested in pursuing careers in patient-oriented research.
Clinical Research Training Scholarship in Lewy Body Diseases – Partnership funding provided with the Alzheimer’s Association and the American Brain Foundation for clinical research with early career investigators in Lewy body diseases.
Clinical Research Training Scholarship in Mal de Debarquement Syndrome and Central Vestibular Neurological Disorders – Partnership funding provided by the MdDs Balance Disorder Foundation and the American Brain Foundation for research studies in Mal de Debarquement Syndrome and Central Vestibular Neurological Disorders.
Clinical Research Training Scholarship in Parkinson’s Disease – Partnership funding with the Parkinson’s Foundation and the American Brain Foundation for clinical studies in Parkinson’s disease.
Clinical Research Training Scholarship in Peripheral Neuropathy – Partnership funding with the Foundation for Peripheral Neuropathy and the American Brain Foundation for studies focused on furthering understanding of disease mechanisms, diagnosis, or treatment of peripheral neuropathy.
Jeanne C. Mayer Multiple Sclerosis Research Award – Partnership funding with the Herbert R. Mayer and Jeanne C. Mayer Foundation through the American Brain Foundation for clinical studies related to multiple sclerosis.
Lawrence M. Brass, MD, Clinical Research Training Scholarship in Stroke – Partnership funding with the American Heart Association and the American Brain Foundation for clinical studies related to stroke, vascular neurology, and neurocritical care.
McKnight Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss – Partnership funding with the McKnight Brain Research Foundation through the American Brain Foundation for studies relevant to age-related cognitive decline and memory loss.
Robert Katzman, MD, Clinical Research Training Scholarship in Alzheimer’s and Dementia Research – Partnership funding with the Alzheimer’s Association and the American Brain Foundation for clinical studies related to Alzheimer’s and related dementias.
Susan S. Spencer, MD, Clinical Research Training Scholarship in Epilepsy – Partnership funding with the American Epilepsy Society, Epilepsy Foundation, and the American Brain Foundation for clinical research training in the field of epilepsy conducted by clinicians who are fellows or new faculty.
- Due: September 9, 2025
- Funding: $240,000
- Project Period: 3 years
- Purpose: In partnership with the Myasthenia Gravis Foundation of America and the American Brain Foundation to support clinical research research studies related to myasthenia gravis.
- Eligibility: PIs must be an AAN member with interest in an academic career in neurological research and have an MD, PhD, or equivalent doctoral-level clinical degree (with completed clinical residency or PHD no more than 5 years prior to July 1, 2026). For MD/PhDs eligibility is based on residency completion date even if a fellowship was completed afterwards. Research should be patient-oriented conducted with human participants, or translational research specifically designed to develop therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
- Due: September 9, 2025
- Funding: $150,000
- Project Period: 2 years
- Purpose: To encourage young investigators in good laboratory or preclinical research and support education and research-related costs.
- Eligibility: Applicants must be interested in a career in neurological research and hold an MD, PhD, or equivalent doctoral-level clinical degree and have completed residency between 5-10 years prior to award start date (July 1, 2026) are eligible. MD/PhDs and post residency fellows’ eligibility is based on residency completion date. Research for this scholarship is defined as patient-oriented research conducted with human subjects or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. However, disease-related studies not directly related to huma subjects or human tissue are still encouraged if the primary goal is to develop therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
- Due: September 9, 2025
- Funding: $150,000
- Project Period: 2 years
- Purpose: To support practice-based research (clinical research that evaluates translation of evidence into best clinical practice), which includes evaluation of health services, quality of care, implementation of therapies, physician performance, or patient adherence, to improve health systems and services.
- Eligibility: AAN members interested in a career in neurological research who hold an MD, PhD, or equivalent doctoral-level clinical degree and have completed residency between 5-10 years prior to award start date (July 1, 2026) are eligible. MD/PhDs and post residency fellows eligibility is based on residency completion date.
- Due: September 9, 2025
- Funding: $240,000
- Project Period: 3 years
- Purpose: To support young investigators conducting clinical research studies in ALS.
- Eligibility: PIs must have an MD, PhD, or equivalent doctoral-level clinical degree (with completed clinical residency or PHD no more than 7 years prior to July 1, 2026). For MD/PhDs eligibility is based on residency completion date even if a fellowship was completed afterwards. Research should be patient-oriented conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease.
- Due: September 15, 2025 (LOI)
- Funding: Up to $5,000,000
- Project Period: Multi-year year
- Purpose: To support new drug (IND)-enabling studies (or international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices to treat Alzheimer’s disease (AD) and related dementias. This grant mechanism focuses on diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia.
- Eligibility: Applicants from academic medical centers, universities, nonprofit organizations, and biotechnology companies may apply. Industry partnerships are encouraged.
- Due: September 15, 2025 (LOI)
- Funding: Up to $600,000
- Project Period: 1 year (potential for follow-on funding based on progress)
- Purpose: To provide funding and project support to further develop and validate established biomarkers to meet clinical needs in Alzheimer’s disease and related dementias. Priority focus: developing novel PET ligands for clinical trials, validating innovative MRI approaches in larger cohorts, and developing novel measures of functional activity such as EEG.
- Eligibility: Applicants from academic medical centers, universities, nonprofit organizations, and biotechnology companies. Industry partnerships are encouraged.
Alzheimer’s Drug Discovery Foundation – Prevention
- Due: September 15, 2025 (LOI)
- Funding: Up to $5,000,000
- Project Period: Multi-year year
- Purpose: To support precision prevention studies (in humans), combination therapy studies, and comparative effectiveness research that explore whether the use or choice of interventions reduces the risk of Alzheimer’s disease or other dementias.
- Eligibility: Applicants from academic medical centers, universities, nonprofit organizations, and biotechnology companies. Industry partnerships are encouraged.
- Due: September 15, 2025
- Funding: $650,000
- Project Period: 3 years
- Purpose: Supports research institutions in building sustained research-practice partnerships with public agencies or nonprofit organizations to improve outcomes for all youth.
- Eligibility: Awards limited to tax-exempt organizations (university-based research institutes, schools, or centers). Eligible PIs should be leaders at eligible research institutions. Check eligibility requirements.
- Due: September 18, 2025
- Funding: $40,000
- Project Period: 1 year
- Purpose: To help early career investigators establish their research careers or to support projects that represent new research directions for established investigators, in celiac disease or gluten-related disorders. For early career applicants this will be a mentored research project. Early career defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent) at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.
- Eligibility: AGA members who hold an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty appointment or equivalent position at an institution in the United States, Canada or Mexico are eligible. Early career is defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.
- Due: September 18, 2025
- Funding: $40,000
- Project Period: 1 year
- Purpose: To provide supplemental funding for early career investigators who currently hold federal or non-federal career development awards focused on conducting research related to pathogenesis, prevention, diagnosis or treatment of digestive cancer. Early career defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.
- Eligibility: AGA members who hold an NIH K series or other federal or non-federal career development award of at least four years in duration, have an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty appointment or equivalent position at an institution in the United States, Canada or Mexico are eligible. Early career is defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent) at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.
- Due: September 18, 2025
- Funding: $100,000
- Project Period: 2 years
- Purpose: To support an established investigator in the gastric cancer research field who is working to enhance fundamental understanding of gastric cancer pathobiology or approaches to prevent, treat or cure gastric cancer.
- Eligibility: Independent investigators (AGA members) in the gastric biology field following the completion of clinical training as a GI fellow or equivalent, who hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO, seven years or more past clinical training or PhD completion) and a full-time faculty appointment or equivalent position at an institution in the United States, Canada or Mexico are eligible.
American Gastroenterological Association (AGA) – AGA Pilot Research Award
- Due: September 18, 2025
- Funding: $40,000
- Project Period: 1 year
- Purpose: To support independent early career investigators and established investigators new directions in gastroenterology- or hepatology-related areas.
- Eligibility: Applicants must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty position or equivalent at an institution in North America (U.S., Canada or Mexico). AGA membership required.
- Due: September 19, 2025
- Funding: $50,000
- Project Period: 1 year
- Purpose: To support independent early career investigators and established investigators new directions in gastroenterology- or hepatology-related areas.
- Eligibility: Applicants must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty position or equivalent at an institution in North America (U.S., Canada or Mexico). AGA membership required.
- Due: September 30, 2025
- Funding: Not specified
- Project Period: Not specified
- Purpose: To support projects focused on research and development of novel diagnostics and treatments for Lyme Disease.
- Eligibility: Applications from universities, hospitals, and independent research entities throughout the U.S. (U.S. only) will be accepted. Previous research experience in Lyme Disease research is not necessary; respected researchers in their fields may leverage their knowledge, abilities, and resourcefulness to develop new concepts, ideas, and methods.
Benign Essential Blepharospasm Foundation – Research Grant
- Due: September 30, 2025
- Funding:stipend Up to $50,000
- Project Period: 1 year
- Purpose: To support research focused on causes, cures, and treatment for blepharospasm.
- Eligibility: Applicants must work at an organization located within the U.S., Canada, or countries where supervision of grant administration is possible. Grantee institution must agree to be bound by the Terms and Conditions of the application.
North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – Advanced Fellowships
- Due: September 30, 2025
- Funding: $75,000
- Project Period: 1 year
- Purpose: To support advanced training for one year in pediatric nutrition for a NASPGHAN member to gain focused clinical research experience.
- Eligibility: NASPGHAN membership for at least 2 years and a mentor is required.
– NASPGHAN Foundation/Abbott Advanced Fellowship Training In Pediatric Nutrition – researchareas to include but are not limited to fetal growth and neonatal nutrition, typical development of feeding skills/behaviors and feeding disorders; nutritional aspects of eating disorders such as anorexia nervosa and bulimia; malnutrition and failure to thrive; nutrition education; nutrition in specific systemic diseases or clinical states such as cystic fibrosis, liver disease, intestinal failure, and organ transplantation; nutrition support; community nutrition; nutrition epidemiology; energy homeostasis; nutrition and the microbiome; micronutrient homeostasis; nutrigenomics; obesity; breast milk and breast feeding; and basic laboratory nutritional science.
– NASPGHAN Foundation Advance Fellowship Training in Pediatric Endoscopy – for focused a research/and or quality improvement project in areas including but not limited to Endoscopic retrograde cholangiopancreatography (ERCP) with stenting and/or sphincterotomy, endoscopic ultrasound (EUS), advanced approaches to control GI bleeding (sclerotherapy, argon laser, clips, etc), transnasal endoscopy, peroral endoscopic myotomy (POEM), esophageal or intestinal stricture dilatation, pancreatic pseudocyst drainage, etc.
November
- Due: November 1, 2025
- Funding: $20,000
- Project Period: 1 year
- Purpose: To support innovative research on coagulation/hematology. This year, Aniara is requesting proposals for projects that deal specifically with Ehlers-Danlos syndrome (EDS) and its effects on hemostasis and thrombosis.
- Eligibility: Established researchers (PhD faculty or equivalent), student or trainee at an academic organization or institution in North America or Scandinavia. Applicants with a minimum of three peer-reviewed publications preferred.
- Due: November 14, 2025
- Funding: Up to $10,000
- Project Period: 1 year
- Purpose: To introduce residents to research through participation in a CF-relevant research project and to spark interest in a career in CF research or as a CF care provider. Priority will be given to projects that will lead to increased understanding of disease mechanisms, pathophysiology, and prevention, and the development of treatment strategies.
- Eligibility: U.S. citizens, permanent residents, or non-U.S. citizens working in a U.S.-based, non-profit or academic institution. Applicants must have completed medical training, hold an MD, DO, or equivalent, and be enrolled in an ACGME accredited residency program in the U.S. for the duration of the award. International applicants must be able to obtain the appropriate visas for application and be certified by the Educational Commission for Foreign Medical Graduates (ECFMG).
- Due: November 15, 2025 (LOI)
- Funding: $300,000
- Project Period: 2 years
- Purpose: To support collaborations between technology, developers and clinical cancer immunologists to generate proof-of-principle of a novel platform technology in bioinformatics that can accelerate the field’s efforts in developing immunotherapies that are effective for all cancer patients.
- Eligibility: Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation or provide documentation from their institution along with the Letter of Intent confirming they will hold the position of assistant professor or higher by the time of award start date.
- Due: November 20, 2025
- Funding: $75,000
- Project Period: 1 year
- Purpose: To provide support for the development and career advancement to research independence of young faculty in the field.
- Eligibility: Active ASN members with and MD, DO, PhD or equivalent working in North America, Central America, or the Caribbean, who are within 10 years of their initial faculty appointment. Appointment to full-time faculty and support as an independent researcher must be confirmed by the department chair. The proposed project must be independent of previous projects with a mentor. Applicants may not have more than $250,000 in annual direct costs in external grant support (including KidneyCare funds), at the time of the award. 75% protected time required.
December
- Due : December 1, 2025
- Funding: $135,000 a year
- Project Period: 3 to 5 years
- Purpose: Supports full-time clinician faculty members in becoming independent investigators as clinician scientists.
- Eligibility: Applicants who work at a US academic institution or eligible non-profit who have a doctoral degree and active clinical license who participate in clinical care and are not a current or former principal investigator of an individual mentored training grant and have not been a PI on an R-level or equivalent grant are eligible.
- Due : December 1, 2025
- Funding: $66,000, $68,000, and $70,000, plus $4,000 fellowship annually (plus $1,500 travel allowance in final year)
- Project Period: Up to 3 years
- Purpose: To support new investigators in research training programs to position them for independent careers in cancer research.
- Eligibility: Applicants with doctoral degrees (less than 4 years) who do not have a faculty appointment and work at a US academic institution or eligible non-profit are eligible. U.S. citizenship, permanent residency, or appropriate visa when you submit your application is required.
- Due : December 1, 2025
- Funding: Up to$215,000 per year
- Project Period: Up to 4 years
- Purpose: To support independent, self-directed researchers working at an U.S. academic institution or eligible non-profit organizations.
- Eligibility: Awards available to support investigators at all levels who have been appointed as independent, full-time faculty less than 10 years ago. Applicant’s institution must provide space and other resources needed by independent investigators.
- Due : December 1, 2025
- Funding: Up to $430,000 per year
- Project Period: Up to 4 years
- Purpose: RUNX1 Research Program and the American Cancer Society (ACS) have partnered to support projects that deepen our understanding of the mechanisms that cause each leukemogenic step (projects should consider experimental designs that address both cell-autonomous and cell-nonautonomous factors), and projects that are high-risk with strong scientific rationale to pursue a cancer interception treatment.
- Eligibility: PIs/teams must work at a U.S. academic institution or eligible non-profit organization and can be full-time independent investigators at any career stage.
LEAP-Research Scholar Grant – supports an independent research project (up to $215,000 per year for independent, self-directed researchers).
- LEAP Team Award – supports an interdisciplinary, synergistic team research project that will accelerate scientific advancement and clinical benefit (up to $430,000 per year).
American College of Gastroenterology (ACG) Institute for Clinical Research and Education & American College of Gastroenterology – 2026 Junior Faculty Development Award
- Due : December 1, 2025
- Funding: $450,000
- Project Period: 3 years
- Purpose: To support junior investigators pursuing independent clinical research careers in gastroenterology or hepatology.
- Eligibility: ACG members who are full-time junior faculty (less than 7 years post GI or Hepatology fellowship training) at a U.S.- or Canadian-based university, medical school or health care institution who hold an MD, MBBS, or DO are eligible. 50% protected time and a preceptor who can provide mentorship is required.
American College of Gastroenterology (ACG) Institute for Clinical Research and Education & American College of Gastroenterology – 2026 Established Investigator Bridge Funding Award RFA
- Due : December 1, 2025
- Funding: $300,000
- Project Period: 2 years
- Purpose: To provide short-term support for established clinical gastroenterology or hepatology investigators while they await federal program funding for their independent research program.
- Eligibility: ACG members who are U.S.- or Canadian-based physicians working as full-time faculty in a astroenterology or hepatology department at a university, medical school or other healthcare institution university. Evidence of recently concluded federal clinical or translational research award as the PI within the last 3 years in gastroenterology or hepatology, such as NIH R01, K-award, or VA Merit Award. National Science Award, Department of Defense and CIHR multi-year project grant awards of equivalency will be considered. Applicants must provide evidence of an ongoing renewal application for federal funding (eRA commons routing information or letter of intent from institutional grant awards office). A letter from the Division Chief or Department Chair must certify that the award will provide 30% protected time to the recipient regardless of the amount budgeted for salary under the terms of the award.
- Due : December 1, 2025 (LOI)
- Funding: $300,000
- Project Period: 2 years
- Purpose: To support pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation (CF), CRI also invites LOIs focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine.
- Eligibility: : Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher) at the time of award start date and be qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.
Jay L. Smith Foundation – Grants
- Due : December 31, 2025 (pre-proposal)
- Funding: Not specified
- Project Period: 1 year
- Purpose: To support research, programs, education and outreach in various areas to include dementia & Alzheimer’s disease, health care access and delivery, elderly care, suicide prevention, and cancer research.
- Eligibility: U.S.-based nonprofit organizations may apply.
Awards
July
- Due : July 15, 2025
- Prize: $30,000 grand prize; $10,000 for each category winner
- Purpose: A global prize to award a young scientist for outstanding research in life sciences in which they obtained a doctoral degree. The winners from each category will compete for the grand prize. The grand prize winner’s essay will be published in Science. Essays from category winners will be published online.
- Eligibility: Applicants must have received their PhD in 2023 or 2024. The subject of their thesis should match one of these Subject Tracks: Cell and Molecular Biology, Genomics, Proteomics and Systems Biology approaches, Ecology and Environment, or Molecular Medicine.
- Due : July 15, 2025
- Prize: $30,000 grand prize; $10,000 for each category winner
- Purpose: A global prize to award a young scientist for outstanding research in life sciences in which they obtained a doctoral degree. The winners from each category will compete for the grand prize. The grand prize winner’s essay will be published in Science. Essays from category winners will be published online.
- Eligibility: Applicants must have received their PhD in 2023 or 2024. The subject of their thesis should match one of these Subject Tracks: Cell and Molecular Biology, Genomics, Proteomics and Systems Biology approaches, Ecology and Environment, or Molecular Medicine.
December
Challenge Works, the Motor Neurone Disease Association & partners – Longitude Prize on ALS
- Due : December 3, 2025
- Prize: Up to $10M
- Project Period: 5 years
- Purpose: An international program that seeks to incentivize the use of AI-based approaches to transform therapeutic discovery for treating amyotrophic lateral sclerosis (ALS) by global multidisciplinary teams to identify, prioritize, and validate high-potential drug targets.
- Eligibility: AI experts, computational biologists and bioinformaticians, neurodegenerative disease and ALS researchers, Biotechnology, techbio and pharmaceutical companies, Data scientists and engineers, and clinical experts and medical researchers may apply.